Mwyngil Therapeutics Inc.
PrivateLast Round
Seed
May 27, 2022
Company Overview
Mwyngil Therapeutics Inc. is a biopharmaceutical company that develops small-molecule therapies for cardiovascular, metabolic, and chronic inflammatory and immune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mwyngil Therapeutics Inc. Comparables
Compare Mwyngil Therapeutics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Novo Nordisk | 80% | |
| NodThera | 78% | |
| Brenig Therapeutics | 76% | |
Mwyngil Therapeutics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 27, 2022 |
Mwyngil Therapeutics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OrbiMed | Seed |
| Torrey Pines Investment LLC | Seed |
| i2020 Accelerator | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 27, 2022
Seed round raised with OrbiMed and Torrey Pines Investment LLC.
Mwyngil Therapeutics Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Mwyngil Therapeutics Inc.'s valuation, stock price, and market status.